Back
NRX Pharmaceuticals Vs. Gossamer Bio Industry Stock Comparison
Sell
45
NRXP
NRX Pharmaceuticals
Last Price:
1.27
Seasonality Move:
44.75%
Sell
25
GOSS
Gossamer Bio
Last Price:
0.70
Seasonality Move:
-16.28%
Sell
45
NRX Pharmaceuticals (NRXP)
is a Sell
Is NRX Pharmaceuticals a Buy, Sell or Hold?
- The current NRX Pharmaceuticals [NRXP] share price is $1.31. The Score for NRXP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NRXP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Gossamer Bio (GOSS)
is a Sell
Is Gossamer Bio a Buy, Sell or Hold?
- The current Gossamer Bio [GOSS] share price is $0.70. The Score for GOSS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- GOSS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NRXP Stock Price Chart
What is NRX Pharmaceuticals's stock price today?
-
The NRX Pharmaceuticals share price today is $1.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRXP is experiencing selling pressure, which indicates risk of future bearish movement.
GOSS Stock Price Chart
What is Gossamer Bio's stock price today?
-
The Gossamer Bio share price today is $0.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOSS is experiencing selling pressure, which indicates risk of future bearish movement.
NRXP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 50.96 | Buy |
Chaikin Money Flow: | -337710 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.21 - 1.33) | Buy |
Bollinger Bands (100): | (1.33 - 2.13) | Sell |
GOSS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 26.96 | Sell |
Chaikin Money Flow: | -1573438 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.74 - 0.92) | Sell |
Bollinger Bands (100): | (0.81 - 1.05) | Sell |
NRXP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.24 | Buy |
20-day SMA: | 1.28 | Buy |
50-day SMA: | 1.39 | Sell |
200-day SMA: | 2.86 | Sell |
8-day EMA: | 1.26 | Buy |
20-day EMA: | 1.28 | Buy |
50-day EMA: | 1.43 | Sell |
200-day EMA: | 2.61 | Sell |
GOSS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.71 | Sell |
20-day SMA: | 0.81 | Sell |
50-day SMA: | 0.91 | Sell |
200-day SMA: | 0.93 | Sell |
8-day EMA: | 0.72 | Sell |
20-day EMA: | 0.79 | Sell |
50-day EMA: | 0.86 | Sell |
200-day EMA: | 0.98 | Sell |
NRX Pharmaceuticals Earnings Growth & NRXP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $0.52 per share.
Gossamer Bio Earnings Growth & GOSS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and a decrease next year of $0.42 per share.
NRX Pharmaceuticals Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Gossamer Bio Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |